Skip to main content

Table 3 Montreal cognitive assessment scale score among BD, SZ, and control groups

From: Cognitive impairment among an Egyptian sample of patients with schizophrenia and bipolar disorders: a comparative study

Parameter

BD (1)

(n = 30)

SZ (2)

(n = 30)

Control (3)

(n = 30)

P value

Between the 3 groups (ANOVA)

MoCA

• Total score

27.1 ± 1.5

24.10 ± 1.4

27.3 ± 1.8

 < 0.001

P value (Mann–Whitney)

(1 vs 2) < 0.001

(2 vs 3) < 0.001

(1 vs 3) 0.44

• Visuospatial

4.8 ± 0.4

3.77 ± 0.7

4.4 ± 0.5

 < 0.001

P value (Mann–Whitney)

(1 vs 2) < 0.001

(2 vs 3) < 0.001

(1 vs 3) 0.002

• Naming

2.87 ± 0.3

2.53 ± 0.5

2.97 ± 0.2

 < 0.001

P value

(1 vs 2) 0.005

(2 vs 3) < 0.001

(1 vs 3) 0.17

• Attention

4.60 ± 0.8

3.93 ± 1.2

4.57 ± 1.0

0.02

P value

(1 vs 2) 0.02

(2 vs 3) 0.046

(1 vs 3) 0.88

• Language

2.73 ± 0.5

2.87 ± 0.3

2.90 ± 0.3

0.24

P value

(1 vs 2) 0.30

(2 vs 3) 0.69

(1 vs 3) 0.16

• Abstraction

2.10 ± 0.3

1.97 ± 0.2

2.00 ± 0.1

0.03

P value

(1 vs 2) 0.045

(2 vs 3) 0.32

(1 vs 3) 0.08

• Delayed recall

4.23 ± 0.5

3.93 ± 0.8

4.67 ± 0.5

 < 0.001

P value

(1 vs 2) 0.12

(2 vs 3) < 0.001

(1 vs 3) 0.002

• Orientation

5.60 ± 0.8

5.03 ± 0.9

5.87 ± 0.3

 < 0.001

P value

(1 vs 2) 0.004

(2 vs 3) < 0.001

(1 vs 3) 0.11

  1. Abbreviations: BD Bipolar disorder, SZ Schizophrenia, SD Standard deviation, IQR Interquartile range, MOCA Montreal Cognitive Assessment Scale